1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
                        
                            
                                申请人:Bernotas Charles Ronald
                            
                            
                                公开号:US20060030593A1
                            
                            
                                公开(公告)日:2006-02-09
                            
                            The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
                            本发明提供了一种I式化合物及其用途,用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病。